Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Receivables Refunds (2016 - 2022)

Historic Receivables Refunds for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Q3 2022 value amounting to $2.1 million.

  • Avadel Pharmaceuticals' Receivables Refunds fell 1668.67% to $2.1 million in Q3 2022 from the same period last year, while for Sep 2022 it was $2.1 million, marking a year-over-year decrease of 1668.67%. This contributed to the annual value of $2.4 million for FY2021, which is 2654.84% down from last year.
  • Avadel Pharmaceuticals' Receivables Refunds amounted to $2.1 million in Q3 2022, which was down 1668.67% from $2.2 million recorded in Q2 2022.
  • In the past 5 years, Avadel Pharmaceuticals' Receivables Refunds registered a high of $3.3 million during Q4 2020, and its lowest value of $283000.0 during Q4 2018.
  • Over the past 5 years, Avadel Pharmaceuticals' median Receivables Refunds value was $2.4 million (recorded in 2021), while the average stood at $2.3 million.
  • Per our database at Business Quant, Avadel Pharmaceuticals' Receivables Refunds soared by 64452.3% in 2019 and then plummeted by 2654.84% in 2021.
  • Avadel Pharmaceuticals' Receivables Refunds (Quarter) stood at $283000.0 in 2018, then skyrocketed by 644.52% to $2.1 million in 2019, then skyrocketed by 57.85% to $3.3 million in 2020, then fell by 26.55% to $2.4 million in 2021, then dropped by 14.98% to $2.1 million in 2022.
  • Its last three reported values are $2.1 million in Q3 2022, $2.2 million for Q2 2022, and $2.4 million during Q1 2022.